| Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading J Dagher, B Delahunt, N Rioux‐Leclercq, L Egevad, JR Srigley, ... Histopathology 71 (6), 918-925, 2017 | 146 | 2017 |
| Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer H Rhee, P Thomas, B Shepherd, S Gustafson, I Vela, PJ Russell, ... The Journal of urology 196 (4), 1261-1267, 2016 | 141 | 2016 |
| Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour H Rhee, J Blazak, CM Tham, KL Ng, B Shepherd, M Lawson, J Preston, ... EJNMMI research 6, 1-6, 2016 | 133 | 2016 |
| Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): can novel molecular biomarkers help solve an old problem? KL Ng, R Rajandram, C Morais, NY Yap, H Samaratunga, GC Gobe, ... Journal of Clinical Pathology 67 (2), 97-104, 2014 | 114 | 2014 |
| Stereotactic radiotherapy and short-course pembrolizumab for oligometastatic renal cell carcinoma—the RAPPORT trial S Siva, M Bressel, ST Wood, MG Shaw, S Loi, SK Sandhu, B Tran, ... European urology 81 (4), 364-372, 2022 | 91 | 2022 |
| A review of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) in renal cell carcinoma (RCC) T Ahn, MJ Roberts, A Abduljabar, A Joshi, M Perera, H Rhee, S Wood, ... Molecular imaging and biology 21, 799-807, 2019 | 68 | 2019 |
| Changing etiology and management patterns for spontaneous renal hemorrhage: a systematic review of contemporary series T Ahn, MJ Roberts, A Navaratnam, E Chung, S Wood International urology and nephrology 49, 1897-1905, 2017 | 66 | 2017 |
| A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma KL Ng, C Morais, A Bernard, N Saunders, H Samaratunga, G Gobe, ... Journal of Clinical Pathology 69 (8), 661-671, 2016 | 62 | 2016 |
| Association of micropapillary urothelial carcinoma of the bladder and BK viruria in kidney transplant recipients S Bialasiewicz, Y Cho, R Rockett, J Preston, S Wood, S Fleming, ... Transplant Infectious Disease 15 (3), 283-289, 2013 | 49 | 2013 |
| Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease H Rhee, KL Ng, BWC Tse, MC Yeh, PJ Russell, C Nelson, P Thomas, ... Pathology 48 (6), 613-616, 2016 | 34 | 2016 |
| Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis G Morgantetti, KL Ng, H Samaratunga, H Rhee, GC Gobe, ST Wood Translational andrology and urology 8 (Suppl 2), S147, 2019 | 27 | 2019 |
| The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a … A Joshi, MJ Roberts, M Perera, E Williams, H Rhee, D Pryor, M Lehman, ... Clinical & Experimental Metastasis 37, 551-560, 2020 | 25 | 2020 |
| Assessment of tumour‐associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear … J Dagher, B Delahunt, N Rioux‐Leclercq, L Egevad, G Coughlin, ... Histopathology 74 (2), 284-290, 2019 | 24 | 2019 |
| Changing trends in surgical management of renal tumours from 2000 to 2016: a nationwide study of Medicare claims data S Ali, T Ahn, N Papa, M Perera, P Teloken, G Coughlin, ST Wood, ... ANZ journal of surgery 90 (1-2), 48-52, 2020 | 22 | 2020 |
| Predictors of new‐onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population‐based analysis T Ahn, RJ Ellis, VM White, DM Bolton, MD Coory, ID Davis, RS Francis, ... Journal of surgical oncology 117 (7), 1597-1610, 2018 | 21 | 2018 |
| Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial S Siva, M Bressel, M Sidhom, S Sridharan, BGL Vanneste, R Davey, ... The Lancet Oncology 25 (3), 308-316, 2024 | 19 | 2024 |
| A simple clinical tool for stratifying risk of clinically significant CKD after nephrectomy: development and multinational validation RJ Ellis, SJ Del Vecchio, KMJ Gallagher, DN Aliano, N Barber, DM Bolton, ... Journal of the American Society of Nephrology 31 (5), 1107-1117, 2020 | 18 | 2020 |
| End-stage kidney disease following surgical management of kidney cancer RJ Ellis, DP Edey, SJ Del Vecchio, M McStea, SB Campbell, CM Hawley, ... Clinical Journal of the American Society of Nephrology 13 (11), 1641-1648, 2018 | 18 | 2018 |
| Association between preoperative hydration status and acute kidney injury in patients managed surgically for kidney tumours RJ Ellis, SJ Del Vecchio, B Kalma, KL Ng, C Morais, RS Francis, GC Gobe, ... International urology and nephrology 50, 1211-1217, 2018 | 18 | 2018 |
| Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma KL Ng, RJ Ellis, H Samaratunga, C Morais, GC Gobe, ST Wood Translational Andrology and Urology 8 (Suppl 2), S123, 2019 | 14 | 2019 |
Handoo RheePrincess Alexandra Hospital在 health.qld.gov.au 的电子邮件经过验证
